Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02880020 |
|
Recruitment Status :
Completed
First Posted : August 26, 2016
Last Update Posted : August 18, 2022
|
Sponsor:
Jonsson Comprehensive Cancer Center
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 9, 2022 |
| Actual Study Completion Date : | August 9, 2022 |